Drug Trial Radar · NCT00344968
Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
Last checked: Nov 19, 2026Latest source record: May 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
956
Actual
Start
Sep 2007
Primary completion
Dec 2009
Study completion Dec 2010
Sponsor
- Lead sponsor
- Alimera SciencesIndustry
- Sponsor type
- Industry
- First posted
- Jun 27, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of an intravitreal insert of fluocinolone acetonide for the treatment of diabetic macular edema.
Conditions
- Diabetic Macular Edema
Interventions
fluocinolone acetonideDrug
0.5 mg fluocinolone acetonide intravitreal insert
Fluocinolone AcetonideDrug
0.2 mg fluocinolone acetonide intravitreal insert
Standard of care laser photocoagulationProcedure
Laser photocoagulation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual AcuityTime frame: 36 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Site not named
Atlanta, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.